EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Journal of Inherited Metabolic Disease

ISSN 0141-8955 · Wiley

Neueste Artikel

  1. Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa

    John J. Mitchell, Jose E. Abdenur, Foekje de Boer, Monica Boyer, Margo Sheck Breilyn, María‐Luz Couce, Diva D. De Leon, Terry G. Derks, Areeg El‐Gharbawy, Andrea B. Haijer‐Schreuder, Karen Loechner, Nicola Longo, Allan M. Lund, Miguel Angel Martinez Olmos, Shawn E. McCandless, Bibiana Mello de Oliveira, Malaya Mount, Nicole Muschol, Kristina Pytlak, Kadakkal Radhakrishnan, Rebecca Riba‐Wolman, David F. Rodriguez‐Buritica, Alessandro La Rosa, Alessandro Rossi, Heather Saavedra, René Santer, Brian Shayota, G. Peter A. Smit, Carolina F. Moura De Souza, Melanie M. van der Klauw, David A. Weinstein, Joseph I. Wolfsdorf, Anne Blake, Andrew A. Grimm, Deepali Mitragotri, Syeda Rahman, Diane M. Turner‐Bowker, Richard Collis

    Erschienen: 2026-09DOI: 10.1002/jimd.70241

  2. First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders

    Giorgia Olivieri, Andrea Bordugo, Birute Burnyte, Alessandro Costetti, Maria‐Luz Couce, Luisa Diogo, Francois Feillet, D. Sean Froese, Benedetta Greco, Jean‐Louis Gueant, Luciana Hannibal, Friederike Hörster, Viktor Kožich, Giancarlo La Marca, Irini Manoli, Fanny Mochel, Lorenzo Orazi, Belén Pérez, Manuel Schiff, Bernd C. Schwahn, Ida Schwartz, Karolina M. Stepien, Jolanta Sykut‐Cegielska, Trine Tangeraas, Rolf H. Zetterström, Carlo Dionisi‐Vici, Martina Huemer

    Erschienen: 2026-07DOI: 10.1002/jimd.70177

  3. 2025 Consensus Clinical Management Guidelines for Niemann‐Pick Disease Type C

    Tarekegn Hiwot, Forbes D. Porter, Tatiana Bremova‐Ertl, Uma Ramaswami, Caroline Hastings, Bénédicte Héron, Justin Hopkin, Joella Melville, Hernan Amartino, Mireia del Toro, Federica Deodato, Fatih Ezgü, Paul Gissen, James B. Gibson, Can Ficicioglu, Roberto Giugliani, Orna Staretz‐Chacham, Frances Platt, Nathalie Guffon, Kristina Julich, Nikola Kresojević, Anna Lehman, Yann Nadjar, Susanne A. Schneider, Simon Jones, Eugen Mengel, Michel Tchan, Mark Walterfang, Ozlem Goker‐Alpan, Charlotte Dawson, Sandra Cowie, Toni Mathieson, Elizabeth Berry‐Kravis, Marc C. Patterson

    Erschienen: 2026-05DOI: 10.1002/jimd.70185

  4. Adults With Acid Sphingomyelinase Deficiency Have Sustained Improvements in Clinical Outcomes With up to 5 Years of Olipudase Alfa Enzyme Replacement Therapy: ASCEND Trial Final Results

    Melissa P. Wasserstein, Carla E. Hollak, Antonio Barbato, Renata C. Gallagher, Roberto Giugliani, Norberto Bernardo Guelbert, Julia B. Hennermann, Takayuki Ikezoe, Robin Lachmann, Olivier Lidove, Paulina Mabe, Eugen Mengel, Maurizio Scarpa, Ebubekir Senates, Michel Tchan, Beth L. Thurberg, Jesus Villarrubia, Nicole M. Armstrong, Shashi Bhushan, Yong Kim, Monica Kumar

    Erschienen: 2026-05DOI: 10.1002/jimd.70192

  5. Shifting Towards Empagliflozin First‐Line Therapy in Glycogen Storage Disease Type Ib: A Nationwide Real‐World Study

    Sema Kalkan Uçar, Neslihan Önenli Mungan, Gülden Fatma Gökçay, Ayşe Çiğdem Aktuğlu Zeybek, Sebile Kılavuz, Seda Güneş, Fatih Kardaş, Pelin Teke Kısa, Kısmet Çıkı, Aynur Küçükçongar Yavaş, Ayça Burcu Kahraman, Merve Yoldaş Çelik, Ebru Canda, Deniz Kor, Meryem Karaca, Tanyel Zübarioğlu, Emine Genç, Havva Yazıcı, Fatma Derya Bulut, Şebnem Kılıç, Hanım Aghakıshılı, Fehime Erdem Karapınar, Ezgi Burgaç, Ertuğrul Kıykım, Alperen Elek, Nihal Kardaş, Ekrem Ünal, Tuba Hilkay Karapınar, Meryem Albayrak, Canan Albayrak, Ayşegül Ünüvar, Saskia B. Wortmann, Deniz Yılmaz Karapınar

    Erschienen: 2026-05DOI: 10.1002/jimd.70198

  6. Natural History of Morquio A Syndrome

    Shunji Tomatsu, Kimberly Klipner, Marie Sahou, Jacky M. Guerrero‐Vargas, Stuart Mackenzie, Lauren Averill, Heidi Kecskemethy, Yasuhiko Ago, Shaukat Khan, Chris Church, Melissa A. Alderfer, Thomas H. Shaffer, Tariq Rahman, Abraham Oommen, Claude Beaty, Emi H. Caywood, Ayaka Silverman, Takeshi Tsuda, Jobayer Hossain, Lan He

    Erschienen: 2026-05DOI: 10.1002/jimd.70199

  7. Pharmacodynamics, Efficacy, and Safety of Intraputaminal Eladocagene Exuparvovec Administered to Pediatric Patients With Aromatic L‐Amino Acid Decarboxylase Deficiency Using an MR ‐Compatible Cannula: 48 Weeks of Follow‐Up

    Daniel J. Curry, Phillip L. Pearl, Scellig S. D. Stone, Donald L. Gilbert, Sudhakar Vadivelu, Bruria Ben‐Zeev, Matthew Vestal, Muhammad Zafar, Chun‐Hwei Tai, Sheng‐Che Chou, Zion Zibly, Lior Ungar, Mered Parnes, Mariam Hull, Lisa Emrick, Christian Werner, Alexis Krolick, Vinay Penematsa, Antonia Wang, Rezwanur Rahman, Lee Golden, Yin‐Hsiu Chien, Paul Wuh‐Liang Hwu

    Erschienen: 2026-03DOI: 10.1002/jimd.70151

  8. Exploring Outcome Measures for Mitochondrial Myopathies; Insights From a Longitudinal Study on TK2 Deficiency

    Paloma Martín‐Jimenez, Laura Bermejo‐Guerrero, Luz Edith Ochoa, María Navarro‐Riquelme, Rocío Garrido‐Moraga, Aurelio Hernández‐Laín, Ana Hernández‐Voth, Adrián González Quintana, Ana Bermejo‐Moriñigo, Violeta González‐Méndez, Cristina Martín‐Arriscado Arroba, Dimitrii Smirnov, Nikita Konstantinovskiy, Joaquín Arenas, Miguel Ángel Martin, Alberto Blázquez, Cristina Domínguez‐González

    Erschienen: 2026-01DOI: 10.1002/jimd.70147

Jahrgänge

2026 · 1062025 · 1872024 · 1132023 · 1132022 · 1212021 · 1422020 · 1442019 · 1272018 · 1552017 · 1002016 · 1012015 · 1312014 · 1182013 · 1272012 · 1272011 · 1472010 · 2012009 · 1572008 · 1482007 · 1792006 · 1532005 · 1582004 · 1312003 · 1192002 · 902001 · 1422000 · 1401999 · 1691998 · 1851997 · 1591996 · 1581995 · 1731994 · 1651993 · 1931992 · 1611991 · 1691990 · 1471989 · 1501988 · 1291987 · 136

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.